| Year |
Citation |
Score |
| 2017 |
Kukreja JB, Porten S, Golla V, Ho PL, Noguera-Gonzalez G, Navai N, Kamat AM, Dinney CPN, Shah JB. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. European Urology Focus. PMID 28753837 DOI: 10.1016/j.euf.2016.12.005 |
0.36 |
|
| 2016 |
Brooks M, Mo Q, Krasnow R, Ho PL, Lee YC, Xiao J, Kurtova A, Lerner S, Godoy G, Jian W, Castro P, Chen F, Rowley D, Ittmann M, Chan KS. Positive association of collagen type I with non-muscle invasive bladder cancer progression. Oncotarget. PMID 27655672 DOI: 10.18632/Oncotarget.12089 |
0.7 |
|
| 2016 |
Parker WP, Ho PL, Boorjian SA, Melquist JJ, Thapa P, Holzbeierlein JM, Frank I, Kamat AM, Lee EK. The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy. World Journal of Urology. PMID 26943643 DOI: 10.1007/s00345-016-1801-y |
0.36 |
|
| 2015 |
Ho PL, Willis DL, Patil J, Xiao L, Williams SB, Melquist JJ, Tart K, Parikh S, Shah JB, Delacroix SE, Navai N, Siefker-Radtke A, Dinney CP, Pisters LL, Kamat AM. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. Urologic Oncology. PMID 26421586 DOI: 10.1016/j.urolonc.2015.08.012 |
0.321 |
|
| 2015 |
Taoka R, Williams SB, Ho PL, Kamat AM. In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 9: E109-13. PMID 25844095 DOI: 10.5489/cuaj.2435 |
0.41 |
|
| 2015 |
Ho PL, Williams SB, Kamat AM. Immune therapies in non-muscle invasive bladder cancer. Current Treatment Options in Oncology. 16: 5. PMID 25757877 DOI: 10.1007/s11864-014-0315-3 |
0.303 |
|
| 2015 |
Kurtova AV, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, Lerner SP, Chen F, Roh TT, Lay E, Ho PL, Chan KS. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature. 517: 209-13. PMID 25470039 DOI: 10.1038/Nature14034 |
0.719 |
|
| 2015 |
Kurtova AV, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, Lerner SP, Chen F, Roh T, Lay E, Ho PL, Chan KS. Abstract 5470: Blocking wound-induced tumor repopulation between chemotherapy cycles as a novel approach to abrogate chemoresistance Cancer Research. 75: 5470-5470. DOI: 10.1158/1538-7445.Am2015-5470 |
0.724 |
|
| 2014 |
Ho PL, Kurtova A, Xiao J, Krasnow R, Lay E, Pazhanisamy S, Lerner SP, Chan KS. Abstract 1928: Reporter construct for functional and real-time evaluation of cytokeratin 14+ bladder cancer stem cells Cancer Research. 74: 1928-1928. DOI: 10.1158/1538-7445.Am2014-1928 |
0.733 |
|
| 2014 |
Ho P, Willis D, Patil J, Tart K, Parikh S, Shah J, Delacroix S, Siefker-Radtke A, Dinney C, Pisters L, Kamat A. MP55-20 OUTCOME OF PATIENTS WITH CLINICALLY NODE-POSITIVE BLADDER CANCER WHO UNDERGO CONSOLIDATIVE SURGERY AFTER PRE-OPERATIVE CHEMOTHERAPY: MD ANDERSON CANCER CENTER EXPERIENCE Journal of Urology. 191. DOI: 10.1016/j.juro.2014.02.1568 |
0.342 |
|
| 2014 |
Golla V, Ho PL, Willis DL, Noguera-Gonzalez G, Navai N, Kamat AM, Dinney CP, Shah J. MP50-20 ABSENCE OF TUMOR ON REPEAT TURBT DOES NOT PREDICT FINAL PATHOLOGIC T0 STAGE IN MUSCLE INVASIVE BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY Journal of Urology. 191. DOI: 10.1016/J.JURO.2014.02.1141 |
0.363 |
|
| 2012 |
Ho PL, Kurtova A, Chan KS. Normal and neoplastic urothelial stem cells: Getting to the root of the problem Nature Reviews Urology. 9: 583-594. PMID 22890301 DOI: 10.1038/Nrurol.2012.142 |
0.72 |
|
| 2012 |
Ho PL, Lay EJ, Jian W, Parra D, Chan KS. Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer Cancer Research. 72: 3135-3142. PMID 22532166 DOI: 10.1158/0008-5472.Can-11-3195 |
0.74 |
|
| 2012 |
Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA, Lotan Y, Beck AH, Chung BI, Alizadeh AA, Godoy G, et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proceedings of the National Academy of Sciences of the United States of America. 109: 2078-83. PMID 22308455 DOI: 10.1073/Pnas.1120605109 |
0.69 |
|
| 2012 |
Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA, Lotan Y, Beck AH, Chung BI, Alizadeh AA, Godoy G, et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes (Proceedings of the National Academy of Sciences of the United States of America (2012) 109, 6 (2078-2083) DOI: 10.1073/pnas.1120605109) Proceedings of the National Academy of Sciences of the United States of America. 109: 3600. DOI: 10.1073/Pnas.1201493109 |
0.655 |
|
| Show low-probability matches. |